Anticarbamylated protein antibodies: The new clinically relevant antibody system in rheumatoid arthritis

被引:0
|
作者
Ajmani, Sajal [1 ]
机构
[1] All India Inst Med Sci, Dept Rheumatol, New Delhi 110029, India
关键词
CARBAMYLATED PROTEINS; AUTOIMMUNITY; PREDICT; SERA;
D O I
10.4103/injr.injr_54_19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:102 / 103
页数:2
相关论文
共 50 条
  • [1] Antibodies to Cartilage Oligomeric Matrix Protein Are Pathogenic in Mice and May Be Clinically Relevant in Rheumatoid Arthritis
    Ge, Changrong
    Tong, Dongmei
    Loennblom, Erik
    Liang, Bibo
    Cai, Weiwei
    Fahlquist-Hagert, Cecilia
    Li, Taotao
    Kastbom, Alf
    Gjertsson, Inger
    Dobritzsch, Doreen
    Holmdahl, Rikard
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (06) : 961 - 971
  • [2] Brief Report: AntiCarbamylated Protein Antibodies Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis
    Shi, Jing
    van de Stadt, Lotte A.
    Levarht, E. W. Nivine
    Huizinga, Tom W. J.
    Toes, Rene E. M.
    Trouw, Leendert A.
    van Schaardenburg, Dirkjan
    ARTHRITIS AND RHEUMATISM, 2013, 65 (04): : 911 - 915
  • [3] Evaluation of the association between anticarbamylated protein antibodies and the longitudinal course of functional ability in rheumatoid arthritis
    Ajeganova, S.
    Svensson, B.
    Huizinga, T. W. J.
    van der Helm-van Mil, A. H. M.
    van Steenbergen, H. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (04) : E14 - U5
  • [4] Diagnostic Accuracy of Anticarbamylated Protein Antibodies in Established Rheumatoid Arthritis: A Monocentric Cross-Sectional Study
    Erre, G. L.
    Mundula, N.
    Colombo, E.
    Mangoni, A. A.
    Sechi, L. A.
    Oggiano, M.
    Irde, R.
    Zinellu, A.
    Passiu, G.
    Carru, C.
    ACR OPEN RHEUMATOLOGY, 2019, 1 (07) : 433 - 439
  • [5] Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system
    Stoop, Jeroen N.
    Fischer, Anita
    Hayer, Silvia
    Hegen, Martin
    Huizinga, Tom W. J.
    Steiner, Guenter
    Trouw, Leendert A.
    Toes, Rene E. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (05) : 949 - 950
  • [6] Response to: 'Evaluation of the association between anticarbamylated protein antibodies and longitudinal course of functional ability in rheumatoid arthritis' by Ajeganova et al
    Humphreys, J. H.
    Symmons, D. P. M.
    Verstappen, S. M. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (04) : E15 - E15
  • [7] Rheumatoid Arthritis: Are Current Research-based Guidelines Clinically Relevant?
    Kafaja, Suzanne
    Furst, Daniel E.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (08) : 1569 - 1570
  • [8] Identification and Validation of Clinically Relevant Clusters of Severe Fatigue in Rheumatoid Arthritis
    Basu, Neil
    Jones, Gareth T.
    Macfarlane, Gary J.
    Druce, Katie L.
    PSYCHOSOMATIC MEDICINE, 2017, 79 (09): : 1051 - 1058
  • [9] Rheumatoid arthritis: new monoclonal antibodies
    Serio, I.
    Tovoli, F.
    DRUGS OF TODAY, 2018, 54 (03) : 219 - 230
  • [10] Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients
    Muller, P. C. E. Hissink
    Anink, J.
    Shi, J.
    Levarht, E. W. N.
    Reinards, T. H. C. M.
    Otten, M. H.
    van Tol, M. J. D.
    Jol-van der Zijde, C. M.
    Brinkman, D. M. C.
    Allaart, C. F.
    Hoppenreijs, E. P.
    Koopman-Keemink, Y.
    Kamphuis, S. S. M.
    Dolman, K.
    van den Berg, J. M.
    van Rossum, M. A. J.
    van Suijlekom-Smit, L. W. A.
    Schilham, M. W.
    Huizinga, T. W. J.
    Toes, R. E. M.
    ten Cate, R.
    Trouw, L. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) : 2053 - 2055